Magnetic resonance prediction of outcome after thrombolytic treatment

Magnetic Resonance Imaging

Volumn 19, Issue 2, 2001, Pages 143-152

  Pillekamp, Frank ^a   Grüne, Matthias ^a   Brinker, Gerrit ^a   Franke, Claudia ^a   Uhlenküken, Ulla ^a   Hoehn, Mathias ^a   Hossmann, Konstantin Alexander ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Diffusion; Perfusion; Prediction; rt PA; Thrombolysis

Indexed keywords

ALTEPLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HEMORRHAGE; BRAIN MAPPING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FIBRINOLYTIC THERAPY; IMAGE ANALYSIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RAT; RISK BENEFIT ANALYSIS; STROKE;

ANIMALS; CEREBRAL HEMORRHAGE; DIFFUSION; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; INFUSIONS, INTRA-ARTERIAL; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; RATS; RATS, SPRAGUE-DAWLEY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

ANIMALIA;

EID: 0035024410     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(01)00293-4     Document Type: Article

References (46)

1. Marler JR, Brott T, Broderick J, Kothari RM, Barsan W, Tomsick T, Spilker J, Miller R, Sauerbeck L, Jarrell J, Kelly J, Perkins T, McDonald T, Rorick M, Hickey C, Armitage J, Perry C, Thalinger K, Rhude R, Schill J, Becker PS, Heath RS, Adams D, Reed R, Klei M, Hughes S, Anthony J, Baudendistel D, Zadicoff C, Rymer M, Bettinger L, Laubinger P, Schmerler M, Meirose G, Lyden P, Rapp K, Babcock T, Daum P, Persona D, Brody M, Jackson C, Lewis S, Liss J, Mahdavi Z, Rothrock J, Tom T, Zweifler R, Dunford J. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
2. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999;340:1781-7.
3. Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997;350:607-14.
4. Trouillas P, Nighoghossian N, Derex L, Adeleine P, Honnorat J, Neuschwander P, Riche G, Getenet JC, Li W, Froment JC, Turjman F, Malicier D, Fournier G, Gabry AL, Ledoux X, Berthezene Y, Ffrench P, Dechavanne M. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke 1998;29:2529-40.
5. von Kummer R, Weber J. Brain and vascular imaging in acute ischemic stroke: the potential of computed tomography. Neurology 1997;49:S52-5.
6. Marks MP, Holmgren EB, Fox AJ, Patel S, von Kummer R, Froehlich J. Evaluation of early computed tomographic findings in acute ischemic stroke. Stroke 1999;30:389-92.
7. Ueda T, Sakaki S, Yuh WT, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 1999;19:99-108.
8. Heiss WD, Grond M, Thiel A, von Stockhausen HM, Rudolf J, Ghaemi M, Lottgen J, Stenzel C, Pawlik G. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998;18:1298-307.
9. Moseley ME, Mintorovitch J, Cohen Y, Asgari HS, Derugin N, Norman D, Kucharczyk J. Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochir 1990;51(Suppl.):207-9.
10. Welch KM, Windham J, Knight RA, Nagesh V, Hugg JW, Jacobs M, Peck D, Booker P, Dereski MO, Levine SR. A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke 1995;26:1983-9.
11. Warach S, Dashe JE, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53-9.
12. Lovblad KO, Laubach HJ, Baird AE, Curtin F, Schlaug G, Edelman RR, Warach S. Clinical experience with diffusion-weighted MR in patients with acute stroke. Am J Neuroradiol 1998;19:1061-6.
13. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998;50:864-70.
14. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-26.
15. Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik RF, Schwamm LH, Buonanno F, Sorensen AG, Gonzalez G. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998;29:939-43.
16. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology 1992;42:235-40.
17. Mintorovitch J, Yang GY, Shimizu H, Kucharczyk J, Chan PH, Weinstein PR. Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na+,K(+)-ATPase activity. J Cereb Blood Flow Metab 1994;14:332-6.
18. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-65.
19. Detre JA, Zhang W, Roberts DA, Silva AC, Williams DS, Grandis DJ, Koretsky AP, Leigh JS. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed 1994;7:75-82.
20. Whittall KP, MacKay AL, Li DK. Are mono-exponential fits to a few echoes sufficient to determine T2 relaxation for in vivo human brain? Magn Reson Med 1999;41:1255-7.
21. Baird AE, Warach S. Magnetic resonance imaging of acute stroke [published erratum appears in J Cereb Blood Flow Metab 1998 Oct; 18(10):preceding 1047]. J Cereb Blood Flow Metab 1998;18:583-609.
22. Mancuso A, Nimura T, Weinstein PR. Prediction of delayed ischemic injury with diffusion-weighted MRI following temporary middle cerebral artery occlusion in rats. Brain Res 1997;760:42-51.
23. Albers GW. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke 1999;30:2230-7.
24. Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolie stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab 1998;18:758-67.
25. Busch E, Krüger K, Hossmann KA. Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res 1997;778:16-24.
26. Overgaard K, Sereghy T, Boysen G, Pedersen H, Hoyer S, Diemer NH. A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab 1992;12:484-90.
27. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Quart 1991;7:1-30.
28. Hoehn-Berlage M, Eis M, Back T, Kohno K, Yamashita K. Changes of relaxation times (T1, T2) and apparent diffusion coefficient after permanent middle cerebral artery occlusion in the rat: temporal evolution, regional extent, and comparison with histology. Magn Reson Med 1995;34:824-34.
29. Kerskens CM, Hoehn-Berlage M, Schmitz B, Busch E, Bock C, Gyngell ML, Hossmann K-A. Ultrafast perfusion-weighted MRI of functional brain activation in rats during forepaw stimulation: comparison with T2*-weighted MRI. NMR Biomed 1996;8:20-3.
30. Hoehn-Berlage M, Eis M, Schmitz B. Regional and directional anisotropy of apparent diffusion coefficient in rat brain. NMR Biomed 1999;12:45-50.
31. Hoehn-Berlage M, Norris DG, Kohno K, Mies G, Leibfritz D, Hossmann KA. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab 1995;15:1002-11.
32. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinanl tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Jama 1995;274:1017-25.
33. Jiang Q, Chopp M, Zhang ZG, Knight RA, Jacobs M, Windham JP, Peck D, Ewing JR, Welch KM. The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat. J Neurol Sci 1997;145:15-23.
34. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Mödder U, Freund HJ. Diffusion- and perfusion-weighled MRI. The DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-7.
35. Sorensen AG, Copen WA, Ostergaard L, Buonanno FS, Gonzalez RG, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Koroshetz WJ. Hyperacute slroke: simullaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999;210:519-27.
36. Franke C, Brinker G, Pillekamp F, Hoehn M. Probability of metabolic tissue recovery after thrombolytic treatment of experimental stroke: a magnetic resonance spectroscopic imaging study in rat brain. J Cereb Blood Flow Metab 2000;20:583-91.
37. Busch E, Krüger K, Allegrini PR, Kerskens CM, Gyngell ML, Hoehn-Berlage M, Hossmann KA. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. J Cereb Blood Flow Metab 1998;18:407-18.
38. Grond M, Stenzel C, Schmülling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29:1544-9.
39. Hossmann KA. Reperfusion of the brain after global ischemia: hemodynamic disturbances. Shock 1997;8:95-101; discussion 2-3.
40. Chien D, Kwong KK, Gress DR, Buonanno FS, Buxton RB, Rosen BR. MR diffusion imaging of cerebral infarction in humans. Am J Neuroradiol 1992;13:1097-102; discussion 103-5.
41. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231-41.
42. Hossmann KA. Resuscitation potentials after prolonged global cerebral ischemia in cats. Crit Care Med 1988;16:964-71.
43. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 1996;16:195-201.
44. Kuroda S, Siesjo BK. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci 1997;4:199-212.
45. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2000;20:937-46.
46. van Dorsten FA, Hata R, Maeda K, Franke C, Eis M, Hossmann KA, Hoehn M. Diffusion- and perfusion-weighted MR imaging of transient focal cerebral ischaemia in mice. NMR Biomed 1999;12:525-34.